[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@Maximus_Holla If you like $PHAT you'll like $ESPR. Profitable soon $120M milestones soon cash to profitability $300M+ revenues next year"
X Link @msp12389 2025-10-15T19:33Z 1019 followers, XXX engagements
"$ESPR setup looks like a high-bar catalyst Japan NHI pricing is already priced in. Approvals done Otsukas ready and the market assumes reimbursement soon. Any delay or weak pricing = downside pressure. Only a big surprise beats expectations now. 7/7"
X Link @Blueeee_Jay 2025-10-15T17:43Z XXX followers, XXX engagements
"Esperions valuation already reflects those projected Otsuka milestone payments and royalties. In other words investors arent valuing $ESPR as a pre-approval company anymore theyre valuing it as a commercial stage biotech awaiting reimbursement confirmation. 4/7"
X Link @Blueeee_Jay 2025-10-15T17:43Z XXX followers, XXX engagements
"Heres why most of the upcoming $espr catalysts are actually high-bar expectations that are already baked into the price: 🧵 1/7"
X Link @Blueeee_Jay 2025-10-15T17:43Z XXX followers, XXX engagements